Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
ranolazine nadolol

increases exposure

Unknown Study
ranolazine naldemedine

increases exposure

Unknown Study
ranolazine nintedanib

increases exposure

Unknown Study
ranolazine paclitaxel

increases exposure

Unknown Theoretical
ranolazine pibrentasvir

increases exposure

Unknown Theoretical
ranolazine relugolix

increases exposure

Unknown Study
ranolazine rimegepant

increases exposure

Unknown Theoretical
ranolazine simvastatin

increases exposure

Unknown Study
ranolazine statins

increases exposure

Unknown Theoretical
ranolazine tacrolimus

increases concentration

Unknown Anecdotal
ranolazine talazoparib

increases exposure

Unknown Study
ranolazine taxanes

increases exposure

Unknown Theoretical
ranolazine thrombininhibitors

increases exposure

Unknown Theoretical
ranolazine tigecycline

increases exposure

Unknown Anecdotal
ranolazine topotecan

increases exposure

Unknown Study
ranolazine trametinib

increases concentration

Unknown Theoretical
ranolazine venetoclax

increases exposure

Unknown Theoretical
ranolazine vincaalkaloids

increases exposure

Unknown Theoretical
rasagiline opioids

increases risk of adverseeffects

Unknown Theoretical
rasagiline pethidine

increases risk of adverseeffects

Unknown Theoretical
reboxetine loopdiuretics

increases risk of hypokalaemia

Unknown Theoretical
reboxetine thiazidediuretics

increases risk of hypokalaemia

Unknown Anecdotal
regorafenib atorvastatin

increases exposure

Unknown Study
regorafenib fluvastatin

increases exposure

Unknown Study
regorafenib methotrexate

increases exposure

Unknown Theoretical
regorafenib rosuvastatin

increases exposure

Unknown Study
regorafenib statins

increases exposure

Unknown Study
regorafenib sulfasalazine

increases exposure

Unknown Study
regorafenib theactivecomponentofsacituzumabgovitecan

increases exposure

Unknown Theoretical
regorafenib topotecan

increases exposure

Unknown Study
ribociclib digoxin

increases exposure

Unknown Theoretical
ribociclib metformin

increases exposure

Unknown Theoretical
ribociclib midazolam

increases exposure

Unknown Study
ribociclib pravastatin

increases exposure

Unknown Theoretical
ribociclib rosuvastatin

increases exposure

Unknown Theoretical
ribociclib sildenafil

increases exposure

Unknown Theoretical
ribociclib statins

increases exposure

Unknown Theoretical
rifabutin antifungals,azoles

decreases concentration

Unknown Study
rifabutin cobicistatandcobicistatincreasestheexposuretorifabutin

decreases concentration

Unknown Study
rifabutin coumarins

decreases anticoagulant effect

Unknown Theoretical
rifabutin elexacaftor

decreases exposure

Unknown Theoretical
rifabutin ledipasvir

decreases exposure

Unknown Theoretical
rifabutin letermovir

decreases concentration

Unknown Theoretical
rifabutin voriconazole

decreases concentration

Unknown Study
rifampicin abrocitinib

decreases exposure

Unknown Study
rifampicin afatinib

decreases exposure

Unknown Study
rifampicin agomelatine

decreases exposure

Unknown Theoretical
rifampicin alfentanil

decreases exposure

Unknown Study
rifampicin aliskiren

decreases exposure

Unknown Study
rifampicin aminophylline

decreases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.